<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Serial cerebral perfusion studies were performed in a patient with <z:e sem="disease" ids="C0026654" disease_type="Disease or Syndrome" abbrv="MYMY|MYMY1">moyamoya disease</z:e>, utilizing N-<z:chebi fb="0" ids="30353">isopropyl</z:chebi> iodoamphetamine (I-123 IMP) </plain></SENT>
<SENT sid="1" pm="."><plain>The SPECT findings correlated closely with those of a CT scan and magnetic resonance imaging (MRI) </plain></SENT>
<SENT sid="2" pm="."><plain>In fact, the perfusion defects seen on SPECT studies were larger than those seen on CT and MRI studies </plain></SENT>
<SENT sid="3" pm="."><plain>The SPECT findings paralleled the patient's improving clinical course </plain></SENT>
<SENT sid="4" pm="."><plain>Cerebral perfusion SPECT studies may be very helpful in the evaluation and follow-up of patients with <z:e sem="disease" ids="C0026654" disease_type="Disease or Syndrome" abbrv="MYMY|MYMY1">moyamoya disease</z:e> </plain></SENT>
</text></document>